Senseonics Announces Pricing of $80 Million Public Offering of Common Stock and Pre-Funded Warrants
Senseonics Holdings, Inc., a medical technology company specializing in implantable continuous glucose monitoring systems, announced an $80 million underwritten public offering of common stock and pre-funded warrants. The proceeds are intended to support the launch of their Eversense 365 system, advance pipeline products, and cover general corporat…